DIAGNOSTIC PRODUCTS CORP
SC 13G/A, 2000-02-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DIAGNOSTIC PRODUCTS CORP, SC 13G/A, 2000-02-01
Next: PENN SERIES FUNDS INC, PRES14A, 2000-02-01



<PAGE>   1


                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, D.C 20549


                                SCHEDULE 13G/A-15


                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 15)*



                         DIAGNOSTIC PRODUCTS CORPORATION
- --------------------------------------------------------------------------------
                                (Name of Issuer)



                           COMMON STOCK, NO PAR VALUE
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)



                                   252450-10-1
               ---------------------------------------------------
                                 (CUSIP Number)



                                DECEMBER 31, 1999
               ---------------------------------------------------
              (Date of Event which Requires Filing This Statement)

     Check the appropriate box to designate the rule pursuant to which this
Schedule is filed.

         [ ]   Rule 13d-1(b)
         [ ]   Rule 13d-1(c)
         [X]   Rule 13d-1(d)


*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).



                                     Page 1
<PAGE>   2


CUSIP NO. 252450-10-1                  13G

1.       NAME OF REPORTING PERSON
         S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  SIGI ZIERING

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP.
                                                                (A) [X]
                                                                (B) [ ]

3.       SEC USE ONLY


4.       CITIZENSHIP OR PLACE OF ORGANIZATION

                  U.S.A.

   NUMBER OF           5.   SOLE VOTING POWER: 2,425,706
    SHARES
 BENEFICIALLY          6.   SHARED VOTING POWER: 18,200
   OWNED BY
EACH REPORTING         7.   SOLE DISPOSITIVE POWER:  2,425,706
  PERSON WITH
                       8.   SHARED DISPOSITIVE POWER: 18,200

9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                  2,443,906

10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

                                                              [ ]

11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

                  17.9%

12.      TYPE OF REPORTING PERSON

                  IN




                                     Page 2
<PAGE>   3


CUSIP NO. 252450-10-1                  13G



1.       NAME OF REPORTING PERSON
         S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

                  MARILYN ZIERING

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP.
                                                               (A) [X]
                                                               (B) [ ]

3.       SEC USE ONLY


4.       CITIZENSHIP OR PLACE OF ORGANIZATION

                  U.S.A.

   NUMBER OF           5.   SOLE VOTING POWER:  2,425,706
    SHARES
 BENEFICIALLY          6.   SHARED VOTING POWER:  18,200
   OWNED BY
EACH REPORTING         7.   SOLE DISPOSITIVE POWER:  2,425,706
  PERSON WITH
                       8.   SHARED DISPOSITIVE POWER: 18,200

9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                  2,443,906

10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

                                                                   [ ]

11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

                  17.9%

12.      TYPE OF REPORTING PERSON

                  IN



                                     Page 3
<PAGE>   4


Item 1(a) Name of Issuer: Diagnostic Products Corporation

Item 1(b) Address of Issuer's Principal Executive Offices:
          5700 West 96th Street
          Los Angeles, California 90045

Item 2(a) Name of Persons Filing:
          Sigi Ziering and Marilyn Ziering, husband and wife

Item 2(b) Address of Principal Office: 5700 West 96th Street
                                       Los Angeles, CA 90045

Item 2(c) Citizenship: U.S.A.

Item 2(d) Title of Class of Securities: Common Stock

Item 2(e) CUSIP Number: 252450-10-1

Item 3    Statement filed Pursuant to Rules 13d-1(b) or 13(d)-2(b) or (c):
          Not Applicable

Item 4(a) Amount Beneficially Owned: 2,425,706 shares are owned by Sigi Ziering
          and Marilyn Ziering as husband and wife. 18,200 shares are owned by
          the mother of Sigi Ziering who resides with Mr. and Mrs. Ziering, as
          to which shares beneficial ownership is disclaimed. Based on the
          foregoing, Sigi Ziering and Marilyn Ziering beneficially own an
          aggregate of 2,443,906 shares.

Item 4(b) Percent of Class: 17.9%.

Item 4(c) For information regarding the number of shares as to which each
          reporting person has voting and dispositive power, see Items 5-8 of
          the cover pages hereto.

Item 5    Ownership of 5% or Less of Class: Not Applicable

Item 6    Ownership of More than 5% on Behalf of Another Person:
          Not Applicable

Item 7    Identification and Classification of the Subsidiary which Acquired the
          Security Being Reported on by the Parent Holding Company:
          Not Applicable

Item 8    Identification and Classification of Members of the Group: The members
          of the group are Sigi Ziering and Marilyn Ziering, husband and wife.

Item 9    Notice of Dissolution of Group: Not Applicable


                                     Page 4
<PAGE>   5

Item 10 Certification: Not Applicable

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

     Pursuant to Rule 13d-1(k)(1), the undersigned agree that this statement is
filed on behalf of each of them.


Dated:  February 1, 2000                    /s/ Sigi Ziering
                                            -----------------------------------
                                            Sigi Ziering


                                            /s/ Marilyn Ziering
                                            -----------------------------------
                                            Marilyn Ziering


                                     Page 5




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission